Literature DB >> 17081499

Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation.

Tiago Fleming Outeiro1, Jochen Klucken, Katherine E Strathearn, Fang Liu, Paul Nguyen, Jean-Christophe Rochet, Bradley T Hyman, Pamela J McLean.   

Abstract

Protein misfolding and inclusion formation are common events in neurodegenerative diseases, such as Parkinson's disease (PD), Alzheimer's disease (AD) or Huntington's disease (HD). Alpha-synuclein (aSyn) is the main protein component of inclusions called Lewy bodies (LB) which are pathognomic of PD, Dementia with Lewy bodies (DLB), and other diseases collectively known as LB diseases. Heat shock proteins (HSPs) are one class of the cellular quality control system that mediate protein folding, remodeling, and even disaggregation. Here, we investigated the role of the small heat shock proteins Hsp27 and alphaB-crystallin, in LB diseases. We demonstrate, via quantitative PCR, that Hsp27 messenger RNA levels are approximately 2-3-fold higher in DLB cases compared to control. We also show a corresponding increase in Hsp27 protein levels. Furthermore, we found that Hsp27 reduces aSyn-induced toxicity by approximately 80% in a culture model while alphaB-crystallin reduces toxicity by approximately 20%. In addition, intracellular inclusions were immunopositive for endogenous Hsp27, and overexpression of this protein reduced aSyn aggregation in a cell culture model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081499      PMCID: PMC1934426          DOI: 10.1016/j.bbrc.2006.10.085

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  50 in total

1.  Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells.

Authors:  W Zhou; M S Hurlbert; J Schaack; K N Prasad; C R Freed
Journal:  Brain Res       Date:  2000-06-02       Impact factor: 3.252

Review 2.  Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases.

Authors:  M Y Sherman; A L Goldberg
Journal:  Neuron       Date:  2001-01       Impact factor: 17.173

Review 3.  Alpha-synuclein and neurodegenerative diseases.

Authors:  M Goedert
Journal:  Nat Rev Neurosci       Date:  2001-07       Impact factor: 34.870

4.  Hsp27 negatively regulates cell death by interacting with cytochrome c.

Authors:  J M Bruey; C Ducasse; P Bonniaud; L Ravagnan; S A Susin; C Diaz-Latoud; S Gurbuxani; A P Arrigo; G Kroemer; E Solary; C Garrido
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

5.  Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.

Authors:  P J McLean; H Kawamata; B T Hyman
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

6.  Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models.

Authors:  Antony A Cooper; Aaron D Gitler; Anil Cashikar; Cole M Haynes; Kathryn J Hill; Bhupinder Bhullar; Kangning Liu; Kexiang Xu; Katherine E Strathearn; Fang Liu; Songsong Cao; Kim A Caldwell; Guy A Caldwell; Gerald Marsischky; Richard D Kolodner; Joshua Labaer; Jean-Christophe Rochet; Nancy M Bonini; Susan Lindquist
Journal:  Science       Date:  2006-06-22       Impact factor: 47.728

7.  Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.

Authors:  Pavan K Auluck; H Y Edwin Chan; John Q Trojanowski; Virginia M Y Lee; Nancy M Bonini
Journal:  Science       Date:  2001-12-20       Impact factor: 47.728

8.  A Drosophila model of Parkinson's disease.

Authors:  M B Feany; W W Bender
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

9.  Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.

Authors:  J M Warrick; H Y Chan; G L Gray-Board; Y Chai; H L Paulson; N M Bonini
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

10.  Identification of genes that modify ataxin-1-induced neurodegeneration.

Authors:  P Fernandez-Funez; M L Nino-Rosales; B de Gouyon; W C She; J M Luchak; P Martinez; E Turiegano; J Benito; M Capovilla; P J Skinner; A McCall; I Canal; H T Orr; H Y Zoghbi; J Botas
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

View more
  65 in total

1.  Hsc70 protein interaction with soluble and fibrillar alpha-synuclein.

Authors:  Samantha Pemberton; Karine Madiona; Laura Pieri; Mehdi Kabani; Luc Bousset; Ronald Melki
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

Review 2.  Drug targets from genetics: α-synuclein.

Authors:  Karin M Danzer; Pamela J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

Review 3.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

Review 4.  Mammalian HspB1 (Hsp27) is a molecular sensor linked to the physiology and environment of the cell.

Authors:  André-Patrick Arrigo
Journal:  Cell Stress Chaperones       Date:  2017-01-31       Impact factor: 3.667

Review 5.  Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.

Authors:  Tessa Sinnige; Anan Yu; Richard I Morimoto
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 6.  Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson's disease.

Authors:  Sandeep K Sharma; Smriti Priya
Journal:  Cell Mol Life Sci       Date:  2016-08-13       Impact factor: 9.261

7.  Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults.

Authors:  Fang Liu; Jagadish Hindupur; Jamie L Nguyen; Katie J Ruf; Junyi Zhu; Jeremy L Schieler; Connie C Bonham; Karl V Wood; V Jo Davisson; Jean-Christophe Rochet
Journal:  Free Radic Biol Med       Date:  2008-04-11       Impact factor: 7.376

8.  The HSP70 molecular chaperone is not beneficial in a mouse model of alpha-synucleinopathy.

Authors:  Derya R Shimshek; Matthias Mueller; Christoph Wiessner; Tatjana Schweizer; P Herman van der Putten
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

9.  The interaction of alphaB-crystallin with mature alpha-synuclein amyloid fibrils inhibits their elongation.

Authors:  Christopher A Waudby; Tuomas P J Knowles; Glyn L Devlin; Jeremy N Skepper; Heath Ecroyd; John A Carver; Mark E Welland; John Christodoulou; Christopher M Dobson; Sarah Meehan
Journal:  Biophys J       Date:  2010-03-03       Impact factor: 4.033

10.  Dopamine-induced conformational changes in alpha-synuclein.

Authors:  Tiago F Outeiro; Jochen Klucken; Kathryn Bercury; Julie Tetzlaff; Preeti Putcha; Luis M A Oliveira; Alexandre Quintas; Pamela J McLean; Bradley T Hyman
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.